Abbott Laboratories vs Elbit Imaging
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Abbott Laboratories is the larger company by market value: $181.1 B against $17 M for Elbit Imaging, 10653 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 7, 2022 for Elbit Imaging). Elbit Imaging's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Abbott Laboratories ABT · #117 in the world | Elbit Imaging EMITF |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇮🇱 Israel |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1888 | — |
| Size | ||
| Market cap | $181.1 B | $17 M* |
| Revenue | $44.3 B | — |
| Net income | $6.5 B | — |
| Employees | 115,000 | — |
| Valuation | ||
| P/E ratio | 38.5× | — |
| Price to sales | 3.8× | — |
| Price to book | 3.5× | — |
| Free cash flow yield | 4.1% | — |
| Profitability | ||
| Gross margin | 56.4% | — |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | — |
| Return on equity | 13.1% | — |
| Return on invested capital | 11.2% | — |
| Growth | ||
| Revenue growth | 5.7% | — |
| Revenue growth, 3 years a year | 0.5% | — |
| Earnings per share growth | -51.3% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 16.7% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2022 |
Questions and answers#
Which is bigger, Abbott Laboratories or Elbit Imaging?
Abbott Laboratories is the larger company by market value: $181.1 B against $17 M for Elbit Imaging, 10653 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 7, 2022 for Elbit Imaging). Elbit Imaging's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.